Absci Corp balance sheet
At the end of fiscal 2025, Absci Corp had total assets of $216m, total liabilities of $26.8m and shareholders' equity of $189m. It held $20.0m in cash against $873,000 of debt: net cash of $19.2m.
Balance sheet
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 70 | 253 | 60 | 72 | 41 | 20 | 108 |
| Receivables | — | — | — | 2 | 0 | — | — |
| Total current assets | 73 | 273 | 187 | 121 | 134 | 150 | 208 |
| Goodwill | 0 | 21 | 21 | 0 | — | — | — |
| Total assets | 89 | 426 | 321 | 217 | 214 | 216 | 269 |
| Accounts payable | 2 | 8 | 2 | 2 | 3 | 3 | 7 |
| Deferred revenue (current) | 3 | 1 | 0 | 3 | 1 | 1 | 1 |
| Total current liabilities | 10 | 34 | 30 | 30 | 29 | 23 | 20 |
| Long-term debt | 4 | 4 | 11 | 8 | 4 | 0 | — |
| Total debt | 5 | 6 | 14 | 11 | 7 | 1 | 0 |
| Total liabilities | 22 | 60 | 47 | 41 | 34 | 27 | 23 |
| Shareholders' equity | −89 | 366 | 274 | 176 | 179 | 189 | 246 |
| Non-controlling interests and other (assets − liabilities − equity) | 156 | — | — | — | — | — | — |
| Net debt (negative = net cash) | −65 | −247 | −46 | −61 | −34 | −19 | −108 |
| Shares outstanding | 18m | — | 92m | 93m | 115m | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | — | 0 | 1 | 1 | 1 | — | — | — |
| Total current assets | 150 | 134 | 156 | 137 | 175 | 150 | 132 | 208 |
| Total assets | 235 | 214 | 232 | 210 | 245 | 216 | 196 | 269 |
| Accounts payable | 2 | 3 | 5 | 8 | 5 | 3 | 9 | 7 |
| Deferred revenue (current) | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| Total current liabilities | 27 | 29 | 27 | 31 | 30 | 23 | 20 | 20 |
| Long-term debt | 2 | 4 | 1 | 0 | 0 | 0 | — | — |
| Total debt | 2 | 4 | 1 | 0 | 0 | 0 | — | — |
| Total liabilities | 34 | 34 | 34 | 37 | 35 | 27 | 24 | 23 |
| Shareholders' equity | 201 | 179 | 199 | 173 | 210 | 189 | 172 | 246 |
| Shares outstanding | 114m | 115m | — | — | — | — | — | — |
Compare with peers
- Ovid Therapeutics Inc. balance sheet
- Cartesian Therapeutics, Inc. balance sheet
- Dare Bioscience, Inc. balance sheet
- Seres Therapeutics, Inc. balance sheet
- Korsana Biosciences, Inc. balance sheet
Head to head: ABSI vs OVIDABSI vs RNACABSI vs DAREABSI vs MCRB
More: Biotechnology stocks compared, Health Care sector, rankings of US companies